Form 4: T2 Biosystems Director Laura Lee Adams Receives 25,000 Restricted Stock Units

Director Laura Lee Adams was granted 25,000 restricted stock units (RSUs) in T2 Biosystems, which will vest in two equal annual installments starting November 4, 2025.

Summary

• Laura Lee Adams, a director at T2 Biosystems, received 25,000 restricted stock units (RSUs) on November 4, 2024.
• These RSUs will vest in two equal annual installments, beginning on November 4, 2025.
• The grant was contingent on stockholder approval of the amendment and restatement of the Issuer's 2014 Incentive Award Plan.
• The stockholders approved the plan amendment on December 30, 2024.
• Each RSU represents a contingent right to receive one share of T2 Biosystems common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of granting equity compensation to a director. It is a positive sign of alignment between management and shareholders, but not a major event.

Positives

• The grant of RSUs to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The RSUs will vest in two equal annual installments beginning on November 4, 2025, contingent on continued service by the director.

Industry Context

The granting of restricted stock units is a common practice for compensating directors and aligning their interests with shareholders in the biotechnology industry.

Comparison to Industry Standards

• RSU grants are a standard form of compensation for directors in publicly traded companies, particularly in the biotech sector.
• Vesting schedules, such as the two-year annual installment plan, are typical to ensure long-term commitment.
• The size of the grant is not benchmarked against industry standards in this document, but is likely based on the company's compensation policies and the director's role.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the director's interests with the company's long-term performance.
• The grant does not have an immediate impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Restricted Stock Units, RSU, Director Compensation, Stock Options, Incentive Award Plan, T2 Biosystems, TTOO, Equity Grant, Corporate Governance